Showing results (3931-3940 of 5,227) with videos related to
Sort By:
Pageof 523
Antiviral Research|June 14, 2002
Virucidal activity and cytotoxicity of the liposomal formulation of povidone-iodineP Wutzler, A Sauerbrei, R Klöcking, et al.Antiviral Research|June 14, 2002
Influenza virus carrying an R292K mutation in the neuraminidase gene is not transmitted in ferretsM L Herlocher, J Carr, J Ives, et al.Antiviral Research|September 11, 2002
Nucleotide triphosphatase/helicase of hepatitis C virus as a target for antiviral therapyPeter Borowski, Sarah Schalinski, Herbert SchmitzAntiviral Research|September 11, 2002
2-Chloro-3-pyridin-3-yl-5,6,7,8-tetrahydroindolizine-1-carboxamide (CMV423), a new lead compound for the treatment of human cytomegalovirus infectionsRobert Snoeck, Graciela Andrei, Bahram Bodaghi, et al.Antiviral Research|September 27, 2002
Antiherpes simplex virus type 2 activity of casuarinin from the bark of Terminalia arjuna LinnHua-Yew Cheng, Chun-Ching Lin, Ta-Chen LinAntiviral Research|July 13, 2001
Influence of virus strain, challenge dose, and time of therapy initiation on the in vivo influenza inhibitory effects of RWJ-270201R W Sidwell, D F Smee, J H Huffman, et al.Antiviral Research|July 13, 2001
Mismatched double-stranded RNA (polyI-polyC(12)U) is synergistic with multiple anti-HIV drugs and is active against drug-sensitive and drug-resistant HIV-1 in vitroR J Essey, B R McDougall, W E RobinsonAntiviral Research|June 29, 2001
Inhibition of cytomegalovirus immediate early gene expression: a therapeutic option?M Scholz, H W Doerr, J CinatlAntiviral Research|June 29, 2001
Inhibition of murine cytomegalovirus and human cytomegalovirus by a novel non-nucleosidic compound in vivoO Weber, W Bender, P Eckenberg, et al.Antiviral Research|September 1, 2001
Novel cell culture systems for the hepatitis C virusR Bartenschlager, V LohmannPageof 523